Attached files
| file | filename |
|---|---|
| EX-23.1 - EXHIBIT 23.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v306802_ex23-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | Financial_Report.xls |
| 10-K - FORM 10-K - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v306802_10k.htm |
| EX-31.1 - EXHIBIT 31.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v306802_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v306802_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v306802_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v306802_ex32-1.htm |
| EX-10.12 - EXHIBIT 10.12 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v306802_ex10-12.htm |
| EX-14.1 - EXHIBIT 14.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v306802_ex14-1.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-1 (No. 333-172241) and on Form S-8 (No. 333-151877) of Weikang Bio-Technology Group Company, Inc. of our report dated March 11, 2011 relating to the financial statements which appear in this Form 10-K.
Goldman Kurland and Mohidin LLP
Encino, California
March 30, 2012